Ocular Therapeutix (OCUL) Gross Margin (2014 - 2026)
Ocular Therapeutix (OCUL) recorded quarterly Gross Margin of 87.68% in Q1 2026, up 3864.93% quarter-over-quarter from 2.21% in Q4 2025, and up 11993.0% on a YoY basis from N/an in Q1 2025.
Ocular Therapeutix (OCUL) Gross Margin (2014 - 2026) Analysis & Trends
Ocular Therapeutix's Gross Margin history runs 13 years deep, the most recent figure standing at 87.68% for Q1 2026.
- In Q1 2026, Gross Margin rose 11993.0% year-over-year to 87.68%; the TTM figure through Mar 2026 stood at 65.4% (up 1144.0% YoY), while the FY2025 annual figure was 3.79%, down 9497.0% from the prior year.
- Gross Margin was 87.68% for Q1 2026 at Ocular Therapeutix, up from 2.21% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 92.81% in Q4 2022 to a low of 147.65% in Q4 2023.
- Historically, Gross Margin has averaged 45.57% across 5 years, with a median of 85.56% in 2025.
- The sharpest annual moves came in 2023 and 2024: Gross Margin tumbled 24046 bps in 2023, then soared 24044 bps in 2024.
- A 5-year view of Gross Margin shows it stood at 92.81% in 2022, then tumbled by 259 bps to 147.65% in 2023, then jumped by 163 bps to 92.8% in 2024, then slumped by 98 bps to 2.21% in 2025, then soared by 3865 bps to 87.68% in 2026.
- The last three Gross Margin figures came in at 87.68% (Q1 2026), 2.21% (Q4 2025), and 87.8% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 79.04% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 86.85% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Ocular Therapeutix | 2.12 Bn | 2.12 Bn | 9.46 Mn | 87.68% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 87.68% |
| Dec 31, 2025 | 2.21% |
| Sep 30, 2025 | 87.80% |
| Jun 30, 2025 | 85.56% |
| Mar 31, 2025 | -32.25% |
| Dec 31, 2024 | 92.80% |
| Sep 30, 2024 | 31.46% |
| Jun 30, 2024 | 90.82% |
| Mar 31, 2024 | 91.02% |
| Dec 31, 2023 | -147.65% |
| Sep 30, 2023 | 38.23% |
| Jun 30, 2023 | 26.56% |
| Mar 31, 2023 | 90.92% |
| Dec 31, 2022 | 92.81% |
| Sep 30, 2022 | 14.87% |
| Jun 30, 2022 | 90.58% |
| Mar 31, 2022 | 31.27% |
| Dec 31, 2021 | 91.00% |
| Sep 30, 2021 | 89.22% |
| Jun 30, 2021 | 28.39% |